Verastem (VSTM) | Stock Overview & Key Data
Verastem Performance Comparison
Stock Range
Today's Range
Low: $5.88
High: $6.33
on August 1, 2025
52 Week Range
Low: $2.10
High: $9.10
on August 5, 2024
on May 27, 2025
All-Time High: $225.84 on July 8, 2013
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$334.1M
EPS
-3.36
P/E Ratio (TTM)
-1.66
Forward P/E
-2.40
P/B Ratio
-10.16
PEG Ratio
-2.40
Div. Yield
N/A
ROE
-2,159.52%
Beta
0.708
Debt to Equity
-2.37
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-1,310.71%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-64.19%
Return on Equity (TTM)
-2,159.52%
EBITDA
$-131.0M
Net Income (TTM)
$-148.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.22
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Verastem VSTM | 334.09M Small-cap | -0.98% | 41.72% | -18.17% | 3.58% | -6.32% | 142.23% | -57.42% | -65.77% |
| Vertex VRTX | 118.67B Large-cap | -1.60% | 2.20% | -7.36% | -1.75% | 13.89% | -6.54% | 60.45% | 69.28% |
| Regeneron REGN | 58.89B Large-cap | -0.75% | 4.48% | -5.28% | -16.19% | -21.86% | -48.36% | -8.92% | -9.89% |
| Harmony Biosciences HRMY | 1.98B Small-cap | -8.32% | 7.40% | 15.20% | -11.75% | -1.23% | 6.17% | -34.48% | -4.44% |
| Denali Therapeutics DNLI | 1.95B Small-cap | -1.68% | -3.66% | -16.31% | -38.46% | -35.51% | -38.55% | -62.41% | -57.48% |
| Amicus Therapeutics FOLD | 1.95B Small-cap | 4.29% | 8.22% | -5.39% | -34.44% | -32.12% | -37.30% | -48.11% | -58.99% |
Ownership & Short Interest
Insider Ownership
0.93%
Institutional Ownership
92.95%
Shares Short
18M
Short Ratio
6.98
Short % of Shares Outstanding
33.10%
Average 10-Day Volume
3M
Average 90-Day Volume
3M
Verastem Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Verastem would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VSTM's 52-week high and low?
- In the last 52 weeks, Verastem reached a high of $9.10 (on May 27, 2025) and a low of $2.10 (on August 5, 2024).
- What is the market cap and P/E ratio for VSTM?
- Curious about Verastem's size and valuation? Its market capitalization stands at 334.09M. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.66, and the forward P/E (looking ahead) is -2.40.
- Does VSTM pay dividends? If so, what's the yield?
- As for dividends, Verastem isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Verastem's main competitors or similar companies to consider before investing?
When looking at Verastem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX118.67B Healthcare Biotechnology -6.54% 60.45% Regeneron
REGN58.89B Healthcare Biotechnology -48.36% -8.92% Harmony Biosciences
HRMY1.98B Healthcare Biotechnology 6.17% -34.48% Denali Therapeutics
DNLI1.95B Healthcare Biotechnology -38.55% -62.41% Amicus Therapeutics
FOLD1.95B Healthcare Biotechnology -37.30% -48.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Verastem Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Verastem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -2,159.52%, the Debt to Equity ratio from the most recent quarter is -2.37, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for VSTM?
- Looking at Verastem's growth, its revenue over the trailing twelve months (TTM) was $10M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of VSTM stock is held by insiders and institutions?
- Wondering who owns Verastem stock? Company insiders (like executives and directors) hold about 0.93% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 92.95%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.